BioAmber Inc. (NYSE: BIOA) disclosed that on January 27th, 2017 BioAmber closed on its previously announced public offering of 4,236,844 units, including full exercise of underwriters’ option, at US $4.75 per unit for gross proceeds of US $20.1 million.
A portion of these securities was issued in Canada on a private placement basis. Rodman & Renshaw, a unit of H.C. Wainwright & Co., acted as the sole book-running manager in connection with this offering and AltaCorp Capital, Cormark Securities and Clarus Securities acted as co-managers.
BioAmber subsequently reimbursed its CDN $25 million or US $19.3 million loan with Bridging Finance Inc. Following the repayment of this loan, BioAmber has no corporate debt.
photo credit: BioAmber
Ted is the architect of CVCA infobase, and is the architect of CPE Media's Financings.ca, Canada's most sophisticated and advanced all private capital and public market financing database.
Latest posts by Ted Liu (see all)
- Berkshire Partners exits Aritzia and founder Brian Hill regains control - February 19, 2019
- Peraso Technologies secures $42M strategic investment - February 19, 2019
- Cansortium files for IPO on CSE - February 11, 2019